Eversight Academy webinar | Antibody-drug conjugates and the ocular surface
December 5 @ 7:30 pm - 8:30 pm
Presenter: Asim V. Farooq, MD
Date: 7:30 p.m. ET Thursday, Dec. 5
Antibody-drug conjugates (ADCs) are a new and growing class of targeted cancer drugs. These drugs commonly cause ocular surface toxicity. This webinar will review what is currently known about ADC-associated ocular surface toxicity and how cornea specialists should approach these patients.
